We showed previously that the expression levels of the ELK3 mRNA and protein differ between subtypes of breast cancer; specifically, ELK3 expression is higher in the aggressive claudin-low type of triple-negative breast cancer (TNBC) than in the luminal type [18]. Here, ELK3 is linked to breast carcinoma.